Description

FORAHALE-400 INHA CAPS: Advanced Dual-Action Airway Control

Product Range: Inspicare Respiratory Care

Composition: Formoterol Fumarate Dihydrate 6 mcg + Budesonide 400 mcg

Format: Dry Powder Inhalation (DPI) Capsules

Product Overview

FORAHALE-400 is a highly effective, synergistic combination therapy designed for the maintenance and management of moderate to severe obstructive airway diseases. By pairing a Long-Acting Beta2-Agonist (LABA) with a potent Inhaled Corticosteroid (ICS) in a convenient Dry Powder Inhaler (DPI) capsule, this formulation addresses both the bronchoconstriction and the underlying inflammation associated with asthma and COPD. It provides patients with rapid symptom relief and long-term disease modification in a single breath-actuated dose.

Mechanism of Action: The Synergistic Approach

This combination works on two distinct but complementary pathways to restore normal breathing:

1. Formoterol (The Bronchodilator): A highly potent LABA that rapidly binds to beta2-receptors in the airway smooth muscle. It provides fast-acting relaxation of the airways (within 1 to 3 minutes) that is sustained for up to 12 hours.
2. Budesonide (The Anti-Inflammatory): A glucocorticoid that acts locally in the lungs to reduce swelling, decrease mucus production, and inhibit the release of inflammatory mediators (like prostaglandins and leukotrienes).

Crucially, the two molecules enhance each other: Budesonide increases the number of beta2-receptors available for Formoterol to bind to, while Formoterol primes the cellular environment, making Budesonide more effective at lower doses.

Key Indications & Uses:

• Asthma Management: For the regular treatment of asthma where use of a combination (ICS and LABA) is appropriate, particularly in patients not adequately controlled with inhaled corticosteroids and “as-needed” short-acting beta2-agonists.
• Severe COPD: For the symptomatic treatment of patients with severe Chronic Obstructive Pulmonary Disease (FEV1 < 50% predicted normal) and a history of repeated exacerbations, who have significant symptoms despite regular bronchodilator therapy.

Standard Dosage:

• Adults (Asthma & COPD): Typically, 1 capsule inhaled twice daily (morning and evening).

Note: The exact dosage should always be titrated to the lowest dose at which effective control of symptoms is maintained, as directed by the prescribing physician.

Key Benefits & Clinical Advantages

• Rapid Onset, Lasting Control: Unlike other LABAs, Formoterol works as quickly as a rescue inhaler (onset in minutes) while providing 12-hour maintenance, leading to immediate patient reassurance and higher adherence.
• Targeted Deep Lung Deposition: The DPI capsule format relies on the patient’s inspiratory flow, eliminating the need for the hand-breath coordination required by standard MDIs (metered-dose inhalers). This ensures the micro-fine powder reaches the deep bronchioles.
• Reduced Exacerbations: Regular use significantly decreases the frequency and severity of asthma attacks and COPD flare-ups, keeping patients out of the emergency room.

Why FORAHALE-400?

Within the Inspicare portfolio, FORAHALE-400 is a high-demand, cornerstone product for pulmonologists and consulting physicians.

• High Patient Compliance: The dual-action formula and easy-to-use DPI format make it easier for patients to stick to their daily routine, translating to consistent monthly refills.
• Broad Prescription Base: Because it addresses both Asthma and COPD, it captures a massive demographic of respiratory patients, from young adults to the elderly.
• Premium Positioning: DPI capsules offer a perceived higher value and superior delivery mechanism compared to traditional inhalers, establishing trust in the brand’s quality.

Partner with Best Biotech: Expand Your Reach in Respiratory Care

Calling all pharma professionals, distributors, and medical representatives! The complete Inspicare Respiratory Care range—featuring high-demand, gold-standard products like FORAHALE-400 INHA CAPS—is open for lucrative partnership opportunities.

At Best Biotech, we are committed to expanding the accessibility of premium, life-saving respiratory therapies across the nation. We actively invite driven industry professionals to join our growing network through our highly rewarding Pharma PCD and Franchise models. Furthermore, our portfolio is fully open for robust direct marketing collaborations.

Whether you are looking to dominate your local territory or expand your existing distribution network, partnering with Best Biotech ensures you are backed by high-quality manufacturing, consistent supply, and a product line that doctors trust. Connect with us to build a profitable, sustainable healthcare business and breathe new life into your entrepreneurial journey.

Quick Links:

1. “India’s AQI is Redlining: Protecting Your Lungs with Science, Strategy, and Immunity”
2. Struggling with the Mucus and Wheeze of COPD? Why Targeting Both Can Be a Game Changer
3. FORAHALE-200 INHA CAPS
4. FORAHALE-400 INHALER: Dosage, Uses & Product Information
5. Can Less ‘Sun-Time’ Drive High Blood Pressure?